Neils Scott C

SEC source: 0001902610-26-000002 · primary_doc.xml · nonDerivative · entry 2

Neils Scott C · CIK 0001902610 · CFO and Assistant Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,215,226

F3 · kind: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F3 · shares: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F2 · balance_after: Includes an aggregate of 869,878 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.

SEC source: 0001902610-26-000002 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · CFO and Assistant Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,243,381

F1 · shares: These shares will vest with respect to 100,000 shares on each of August 15, 2027, August 15, 2028, August 15, 2029, and August 15, 2030 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes an aggregate of 869,878 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.

SEC source: 0001902610-26-000001 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · CFO and Assistant Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 843,381

F1 · kind: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F1 · shares: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F2 · balance_after: Includes an aggregate of 498,914 shares issuable upon vesting and settlement of restricted stock unit (RSU) awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and 62,974 shares issuable upon vesting and settlement of RSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.

SEC source: 0001902610-25-000005 · primary_doc.xml · derivative · entry 2

Neils Scott C · CIK 0001902610 · CFO and Assistant Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 526,582

Underlying: Common Stock · 526,582 shares

Expires 2028-11-15

F3 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the Issuer's common stock. The PSUs will vest and become earned in one-third increments based on the achievement of specified stock price performance goals during a three-year performance period and subject to additional service-based vesting conditions.

F4 · shares: Represents the maximum number of shares that may be issued pursuant to the PSUs, which is 200% of the target number of shares (263,291).

F3 · derivative.exercise_date: Each PSU represents a contingent right to receive one share of the Issuer's common stock. The PSUs will vest and become earned in one-third increments based on the achievement of specified stock price performance goals during a three-year performance period and subject to additional service-based vesting conditions.

F4 · derivative.underlying_shares: Represents the maximum number of shares that may be issued pursuant to the PSUs, which is 200% of the target number of shares (263,291).

F4 · balance_after: Represents the maximum number of shares that may be issued pursuant to the PSUs, which is 200% of the target number of shares (263,291).

SEC source: 0001902610-25-000005 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · CFO and Assistant Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 851,465

F1 · shares: These shares will vest with respect to 65,822 shares on each of November 15, 2026, November 15, 2027, and November 15, 2028, and with respect to 65,825 shares on November 5, 2029 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes an aggregate of 498,914 shares issuable upon vesting and settlement of restricted stock unit (RSU) awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and 85,220 shares issuable upon vesting and settlement of RSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.

SEC source: 0001902610-25-000003 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 588,174

F1 · kind: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F1 · shares: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F2 · balance_after: Includes an aggregate of 235,623 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 85,220 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.

SEC source: 0001235802-25-000006 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 622,305

F1 · kind: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F2 · balance_after: Includes an aggregate of 264,659 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 167,726 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.

SEC source: 0001235802-24-000065 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 630,291

F1 · kind: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F1 · shares: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F2 · balance_after: Includes an aggregate of 264,659 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 189,972 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.

SEC source: 0001235802-24-000027 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 664,423

F1 · shares: These shares will vest with respect to 44,388 shares on each of April 3, 2025, April 3, 2026, and April 3, 2027 and with respect to 44,387 shares on April 3, 2028 pursuant to a deferred stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares, however, will occur at a later date pursuant to the terms of the award agreement.

F2 · balance_after: Includes an aggregate of 293,695 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 205,739 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting dates.

SEC source: 0001235802-24-000013 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 486,872

F1 · kind: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F1 · shares: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

F2 · balance_after: Includes 116,144 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 205,739 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.

SEC source: 0001235802-23-000097 · primary_doc.xml · derivative · entry 3

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,501

Underlying: Common Stock · 135,501 shares

Expires 2033-08-15

F3 · derivative.exercise_date: This option vests with respect to 33,875 shares on August 15, 2024 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.

SEC source: 0001235802-23-000097 · primary_doc.xml · nonDerivative · entry 2

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 494,858

F2 · balance_after: Includes 116,144 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 227,985 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.

SEC source: 0001235802-23-000097 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 520,104

F1 · shares: These shares will vest and be issued with respect to 29,036 shares on each of August 15, 2024, August 15, 2025, August 15, 2026 and August 15, 2027 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.

F2 · balance_after: Includes 116,144 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 227,985 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.

SEC source: 0001235802-23-000017 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 403,960

F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6002 to $0.62, inclusive. The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

F3 · balance_after: Includes 58,594 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and 318,633 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan.

SEC source: 0001235802-22-000100 · primary_doc.xml · nonDerivative · entry 3

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 412,633

F3 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.47 to $0.4953, inclusive. The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.

F2 · balance_after: Includes 58,594 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and 340,878 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan.

SEC source: 0001235802-22-000100 · primary_doc.xml · nonDerivative · entry 2

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 413,903

F3 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.47161 to $0.517084, inclusive. The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

F2 · balance_after: Includes 58,594 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and 340,878 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan.

SEC source: 0001235802-22-000100 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,003

F1 · shares: These shares will vest and be issued with respect to 62,974 shares on each of August 15, 2023, August 15, 2024, and August 15, 2025 and with respect to 62,973 shares on August 15, 2026 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date

F2 · balance_after: Includes 58,594 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and 340,878 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan.

SEC source: 0001235802-22-000017 · primary_doc.xml · derivative · entry 2

Neils Scott C · CIK 0001902610 · Interim Chief Financial Office

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,164

Underlying: Common Stock · 109,164 shares

Expires 2032-01-15

F3 · derivative.exercise_date: This option vests with respect to 27,291 shares on January 15, 2023 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.

SEC source: 0001235802-22-000017 · primary_doc.xml · nonDerivative · entry 1

Neils Scott C · CIK 0001902610 · Interim Chief Financial Office

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,108

F1 · shares: These shares will vest and be issued with respect to 22,246 shares on each of January 15, 2023, January 15, 2024, and January 15, 2025 and with respect to 22,245 shares on January 15, 2026 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.

F2 · balance_after: Includes 78,125 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and 88,983 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan.